Taisho Pharmaceutical Holdings Co., Ltd.
TAIPY
Price:
$14
Market Cap:
$703.28B
Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
TAIPY
PE Ratio
[93.33]
ROE
[1.26%]
Current Ratio
[5.16]
Dividend Yield
[0.58%]
Enterprise Value
[466.10B]
Dividend History
The ROE as of December 2024 (TTM) for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) is 1.26%
According to Taisho Pharmaceutical Holdings Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 1.26%. This represents a change of 393.15% compared to the average of 0.25% of the last 4 quarters.
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Historical ROE (quarterly & annually)
How has TAIPY ROE performed in the past?
The mean historical ROE of Taisho Pharmaceutical Holdings Co., Ltd. over the last ten years is 3.76%. The current 1.26% ROE has changed -66.60% with respect to the historical average. Over the past ten years (40 quarters), TAIPY's ROE was at its highest in in the September 2018 quarter at 4.04%. The ROE was at its lowest in in the March 2019 quarter at -0.39%.
Average
3.76%
Median
3.70%
Minimum
1.75%
Maximum
6.82%
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) ROE by Quarter and Year
Discovering the peaks and valleys of Taisho Pharmaceutical Holdings Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.27%
Maximum Annual ROE = 6.82%
Minimum Annual Increase = -58.44%
Minimum Annual ROE = 1.75%
| Year | ROE | Change |
|---|---|---|
| 2023 | 2.42% | 37.70% |
| 2022 | 1.75% | -3.91% |
| 2021 | 1.83% | -35.56% |
| 2020 | 2.83% | -58.44% |
| 2019 | 6.82% | 45.27% |
| 2018 | 4.69% | 5.95% |
| 2017 | 4.43% | 23.99% |
| 2016 | 3.57% | -6.80% |
| 2015 | 3.83% | -29.64% |
| 2014 | 5.45% | 17.08% |
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Average ROE
How has TAIPY ROE performed in the past?
The current ROE of Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.00%
5-year avg
3.13%
10-year avg
3.76%
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) ROE vs. Peers
How is TAIPY’s ROE compared to its peers?
Taisho Pharmaceutical Holdings Co., Ltd.’s ROE is less than Shionogi & Co., Ltd. (12.38%), greater than Vivesto AB (-83.88%), less than Acorda Therapeutics, Inc. (485.80%), greater than Pacira BioSciences, Inc. (-10.70%), less than Haleon plc (0%), less than Dr. Reddy's Laboratories Limited (6.54%), less than Emergent BioSolutions Inc. (18.58%), greater than HUTCHMED (China) Limited (-37.83%), greater than Viatris Inc. (-5.71%), greater than Teva Pharmaceutical Industries Limited (-4.43%), greater than Elanco Animal Health Incorporated (-14.58%), less than Catalent, Inc. (3.31%), greater than Mallinckrodt plc (-11.44%), greater than null (-74.45%),
| Company | ROE | Market cap |
|---|---|---|
| 12.38% | $12.05B | |
| -83.88% | $13.26M | |
| 485.80% | $821.03K | |
| -10.70% | $898.99M | |
| 0% | $44.09B | |
| 6.54% | $13.05B | |
| 18.58% | $449.73M | |
| -37.83% | $2.49B | |
| -5.71% | $14.80B | |
| -4.43% | $25.44B | |
| -14.58% | $5.87B | |
| 3.31% | $11.52B | |
| -11.44% | $4.52M | |
| -74.45% | $0 |
Build a custom stock screener for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taisho Pharmaceutical Holdings Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Taisho Pharmaceutical Holdings Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Taisho Pharmaceutical Holdings Co., Ltd.'s ROE?
How is the ROE calculated for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
What is the highest ROE for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
What is the 3-year average ROE for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
What is the 5-year average ROE for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
How does the current ROE for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) compare to its historical average?